Pataky Zoltan, Herrmann François R, Regat Delphine, Vuagnat Hubert
Department of Rehabilitation and Geriatrics, General Medical Rehabilitation Service, Loëx Hospital, University Hospitals of Geneva, Geneva, Switzerland.
Gerontology. 2008;54(6):349-53. doi: 10.1159/000129685. Epub 2008 Apr 30.
The prevalence of the at-risk foot in patients with diabetes is high and is increasing with age. The screening of the at-risk foot should be performed in all geriatric patients and on a regular basis.
To estimate the prevalence of at-risk foot in a geriatric population of patients and to identify associated principal risk factors in patients with diabetes, nondiabetic patients with neurological disorders and subjects without any known cause of sensory loss at the lower limb.
A longitudinal prospective study has been conducted in a university long-term care facility with mostly geriatric patients.Four hundred and twenty-six consecutive hospital admissions were recruited between October 2005 and September 2006.Lower limb neuropathy (LLN) was evaluated by the vibration perception threshold using a 128-Hz Rydel-Seiffer tuning fork. Peripheral vascular disease (PVD) was evaluated by the Doppler technique. Patients with LLN and/or PVD were considered to have at-risk foot.
Of the 426 participants (median age 80 years, range 26-97), 110 (25.8%) had LLN, 82 (19.2%) had PVD and 92 (21.6%) had both LLN and PVD. Diagnosed diabetes mellitus was present in 96 (22.5%) patients and different neurological disorders having impact on foot sensitivity in 100 (23.5%) patients. The prevalence of the at-risk foot was similar in patients with diabetes (68.7%), in nondiabetic patients with chronic neurological medical conditions (66.0%), or in those without any evidence of diabetes or neurological disease (66.1%). Age was shown to be a predictive factor for the presence of LLN (OR 1.02, 95% CI 1.01-1.04, p = 0.002).
The prevalence of the at-risk foot in geriatric patients is high, independently of the presence of diabetes. The results suggest that both nondiabetic patients and patients with chronic neurological disorders should be screened for the presence of LLN and PVD as diabetic patients. This screening should be mandatory both in institutions and at home by the general practitioner(s).
糖尿病患者中足部高危人群的患病率较高,且随年龄增长而增加。所有老年患者均应定期进行足部高危筛查。
评估老年患者人群中足部高危的患病率,并确定糖尿病患者、患有神经疾病的非糖尿病患者以及下肢无任何已知感觉丧失原因的受试者的相关主要危险因素。
在一所主要收治老年患者的大学长期护理机构中进行了一项纵向前瞻性研究。2005年10月至2006年9月期间连续招募了426例住院患者。使用128赫兹的里德尔-西弗音叉通过振动觉阈值评估下肢神经病变(LLN)。通过多普勒技术评估外周血管疾病(PVD)。患有LLN和/或PVD的患者被视为足部高危患者。
在426名参与者(中位年龄80岁,范围26 - 97岁)中,11名(25.8%)患有LLN,82名(19.2%)患有PVD,92名(21.6%)同时患有LLN和PVD。96名(22.5%)患者被诊断患有糖尿病,100名(23.5%)患者患有影响足部感觉的不同神经疾病。糖尿病患者(68.7%)、患有慢性神经疾病的非糖尿病患者(66.0%)或无任何糖尿病或神经疾病证据的患者(66.1%)中足部高危的患病率相似。年龄被证明是LLN存在的预测因素(比值比1.02,95%置信区间1.01 - 1.04,p = 0.002)。
老年患者中足部高危的患病率较高,与糖尿病的存在无关。结果表明,非糖尿病患者和患有慢性神经疾病的患者应与糖尿病患者一样接受LLN和PVD的筛查。这种筛查在机构和家庭中均应由全科医生强制执行。